发明名称 COMPOUNDS WHICH INHIBIT THE GLYCINE TRANSPORTER AND USES THEREOF
摘要 Compounds of formula (I) and salts and solvates are provided wherein R<SUP>2</SUP> is selected from phenyl substituted with n R<SUP>1</SUP> groups, and pyridyl substituted with n R<SUP>1</SUP> groups; n = 0, 1 or 2; each R<SUP>1</SUP> is independently selected from the group consisting of halo, C<SUB>1-4</SUB>alkyl, C<SUB>1-4</SUB>alkoxy, haloC<SUB>1-4</SUB>alkyl, haloC<SUB>1-4</SUB>alkoxy and cyano; R<SUP>3</SUP> is selected from hydrogen and C<SUB>1-2</SUB> alkyl; R<SUP>4</SUP> is selected from the group consisting of ethyl, n- propyl, i-propyl, n-butyl, i-butyl and t-butyl; or R<SUP>3</SUP> and R<SUP>4</SUP> together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocyclic ring optionally substituted with one or more groups X; each X is independently selected from the group consisting of C<SUB>1-4</SUB>alkyl, and haloC<SUB>1-4</SUB>alkyl; R<SUP>12</SUP> is selected from the group consisting of hydrogen, fluoro, chloro, bromo, methyl and methylthio; R<SUP>13</SUP> is selected from hydrogen, chloro and trifluoromethyl; R<SUP>14</SUP> is selected from hydrogen, trifluoromethyl and chloro; R<SUP>15</SUP> is selected from hydrogen, chloro and trifluoromethyl; R<SUP>16</SUP> is selected from hydrogen, methyl, fluoro and chloro; R<SUP>12</SUP>, R<SUP>13</SUP>, R<SUP>14</SUP>, R<SUP>15</SUP> and R<SUP>16</SUP> not all simultaneously being hydrogen. Processes for the preparation and uses of the compounds as medicaments for treating disorders such as psychoses, dementia or attention deficit disorder are also disclosed.
申请公布号 WO2007113309(A3) 申请公布日期 2008.09.12
申请号 WO2007EP53275 申请日期 2007.04.03
申请人 GLAXO GROUP LIMITED;COULTON, STEVEN;GILPIN, MARTIN;PORTER, RODERICK, ALAN 发明人 COULTON, STEVEN;GILPIN, MARTIN;PORTER, RODERICK, ALAN
分类号 C07C211/27;A61K31/166;A61K31/40;A61K31/445;A61P25/28;C07C233/78;C07D213/40;C07D295/13 主分类号 C07C211/27
代理机构 代理人
主权项
地址